GlassScriptPhysician profile
Paul Vetter
NPI 1457328064
$531.48
in general payments reported to CMS, 2019-2025
17 companies · $115 in 2025
The $115 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $77.82 · 2020: $32.30 · 2021: $47.39 · 2022: $114 · 2023: $83.14 · 2024: $61.17 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $259.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $97.89 | 2019-2025 | Veozah, Myrbetriq |
| Organon LLC | $59.33 | 2023-2024 | Jada System |
| Bayer Healthcare Pharmaceuticals INC. | $47.49 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $45.09 | 2025 | Exparel |
| Abbvie INC. | $43.72 | 2020-2022 | |
| Coloplast Corp | $34.57 | 2021 | |
| Dilon Technologies, INC. | $28.99 | 2025 | Hemoblast Bellows |
| Mayne Pharma Commercial LLC | $27.95 | 2022-2025 | |
| Pfizer INC. | $26.30 | 2021-2023 | |
| Smith+Nephew, INC. | $18.50 | 2019 | |
| Allergan, INC. | $15.37 | 2019 | |
| Daiichi Sankyo INC. | $15.26 | 2022 | |
| Therapeuticsmd, INC. | $14.96 | 2022 | |
| Coopersurgical, INC. | $14.63 | 2023 | Paragard T 380a |
| Sumitomo Pharma America, INC. | $14.35 | 2023 | Myfembree |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $13.55 | 2022 | |
| Agile Therapeutics, INC. | $13.53 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Vetter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.